MiMedx Group, Inc. announced that its outstanding 95,000 shares of Series B Convertible Preferred Stock, together with any accrued dividends, were automatically converted into shares of the Company’s Common Stock on December 22, 2023, in accordance with the Preferred Stock terms set forth in the Company’s Articles of Incorporation.
December 28, 2023
· 3 min read
